ライフサイエンスコーパス: chylous

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 umothorax (n = 3), chylous effusion (n = 1), chylous ascites (n = 3), complications from renal angiom

2 Complications included one patient with chylous ascites and one with a prolonged air leak, both

3 Chylous ascites refers to the accumulation of lipid-rich

4 ion from blood, and their presence in urine, chylous ascites, and pleural effusions are consistent wi

5 edema, secondary lymphedema, chylothorax and chylous ascites, lymphatic malformations, and overgrowth

6 lature, resulting in perinatal appearance of chylous ascites.

7 rmalities, extensive hepatocyte necrosis and chylous ascites.

8 ficient mice, with subsequent development of chylous ascites.

9 s, but who was determined to actually have a chylous cyst, is described herein.

10 Chylous cysts of the neck or chest wall can be caused by

11 s (n = 4), native lung pneumothorax (n = 3), chylous effusion (n = 1), chylous ascites (n = 3), compl

12 Standard therapy for chylous effusion with the addition of pressure control v

13 eginning sirolimus therapy, 12 patients with chylous effusions and 11 patients with lymphangioleiomyo

14 f lung function and reduction in the size of chylous effusions and lymphangioleiomyomas in patients w

15 le and serious complications associated with chylous effusions are well known.

16 is characterized by cystic lung destruction, chylous effusions, lymphangioleiomyomas, and angiomyolip

17 tic intervention in patients with persistent chylous effusions.

18 Chylous fistulas resolved in 5 to 16 days (mean time 12.

19 from 11 of 14 (79%) patients with AML and in chylous fluid from 1 of 3 (33%) patients.

20 lymphangiectasia, chylolymphatic reflux, and chylous leak.

21 Chylous leakage (CL) is a rare complication of laparosco

22 og, i.a.) abolished the afferent response to chylous lymph in 83% of these units.

23 Chylous lymph was significantly more potent than control

24 on of lipid (Intralipid, 170 micromol h(-1), chylous lymph) or a dextrose and/or electrolyte solution

25 de, 1 mg kg(-1), i.v.) significantly reduced chylous lymph-induced inhibition of gastric motility.

26 was increased by close-arterial injection of chylous lymph; devazepide (100 microg, i.a.) abolished t

27 Chylous pleural effusion (chylothorax) frequently accomp

28 phatic involvement-thoracic duct dilatation, chylous pleural effusion, ascites, and LALM-is more comm

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。